000			02143 a2200601 4500
005			20250517034259.0
264		0	_c20160621
008			201606s 0 0 eng d
022			_a1559-1182
024	7		_a10.1007/s12035-015-9234-y _2doi
040			_aNLM _beng _cNLM
100	1		_aRequejo, C
245	0	0	_aTopographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. _h[electronic resource]
260			_bMolecular neurobiology _cOct 2015
300			_a846-58 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aDNA Replication
650	0	4	_aDoublecortin Domain Proteins
650	0	4	_aDoublecortin Protein
650	0	4	_aDrug Synergism
650	0	4	_aDrug Therapy, Combination
650	0	4	_aGlial Cell Line-Derived Neurotrophic Factor _xadministration & dosage
650	0	4	_aGlial Fibrillary Acidic Protein _xanalysis
650	0	4	_aInjections, Intralesional
650	0	4	_aMale
650	0	4	_aMicrotubule-Associated Proteins _xanalysis
650	0	4	_aNanocapsules
650	0	4	_aNerve Tissue Proteins _xanalysis
650	0	4	_aNeuroglia _xchemistry
650	0	4	_aNeurons _xchemistry
650	0	4	_aNeuropeptides _xanalysis
650	0	4	_aOxidopamine _xtoxicity
650	0	4	_aParkinsonian Disorders _xdrug therapy
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aTissue Distribution
650	0	4	_aTyrosine 3-Monooxygenase _xanalysis
650	0	4	_aVascular Endothelial Growth Factor A _xadministration & dosage
700	1		_aRuiz-Ortega, J A
700	1		_aBengoetxea, H
700	1		_aGarcia-Blanco, A
700	1		_aHerrán, E
700	1		_aAristieta, A
700	1		_aIgartua, M
700	1		_aUgedo, L
700	1		_aPedraz, J L
700	1		_aHernández, R M
700	1		_aLafuente, J V
773	0		_tMolecular neurobiology _gvol. 52 _gno. 2 _gp. 846-58
856	4	0	_uhttps://doi.org/10.1007/s12035-015-9234-y _zAvailable from publisher's website
999			_c24950134 _d24950134